Spikevax Bivalent (original / Omicron Ba.4/5) (elasomeran/davesomeran) Covid-19 Vaccine With English-only Vial And Carton Labels
Recall Summary Moderna's SPIKEVAX Bivalent COVID-19 vaccine is being recalled across Canada due to labeling issues on vials and cartons that only have English-language labels. The recall affects the specific batch of this booster vaccine formulated for the Original strain and Omicron BA.4/5 variants. The labeling problem relates to product safety and regulatory compliance requirements for pharmaceutical packaging in Canada.
- Product
- SPIKEVAX Bivalent (Original / Omicron BA.4/5) (elasomeran/davesomeran) COVID-19 Vaccine
- Reason
- Labelling - Packaging - Product safety - Supply - COVID
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2022-11-18
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/ede39049-cb93-4fd8-9916-bcf55bf6849d